<DOC>
	<DOCNO>NCT02133287</DOCNO>
	<brief_summary>To evaluate The Safety Efficacy 'AVI ' Stent Comparing Firebird2® For Treating Coronary Revascularization .</brief_summary>
	<brief_title>To Evaluate The Safety Efficacy 'AVI ' Stent Comparing With Firebird2® For Treating Coronary Revascularization</brief_title>
	<detailed_description>The study Prospective , Open-lable , Multi-center , Randomized trial . 2000 primary coronary artery disease patient enrol 1:1 randomization ratio ( AVI:1000 , Firebird 2:1000 ) approximately 40 site , Subject follow-up 30 day , 6 month , 9 month , 12 month , 2-5 year procedure .</detailed_description>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Arsenic trioxide</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<criteria>1 . Patient must least 18 year age . 2 . Ischemic heart symptom and/or myocardial ischemia , include chronic stable/unstable coronary artery disease acute coronary syndrome ( ST elevate MI NonST elevate MI ) 3 . At least one lesion diameter stenosis ( DS ) ≥70％ , reference vessel diameter ≥2.5mm , ≤3.5mm . 4 . If subject multiple vessel lesion , implanted stent must brand . The staged procedure allow within 3 month procedure , implanted stent must brand stent index procedure . 5 . Subject CABG contraindication . 6 . Subject legal representative inform property study , understand stipulation protocol , ensure compliance sign ICF . 1 . Pregnant nursing patient plan become pregnant 1 year post index procedure . 2 . Subject tendency bleed coagulation disorder , contraindication antiplatelet and/or anticoagulant therapy , ca n't accept continue DAPT within 6 month . 3 . Poor compliance expectation life less 1 year . 4 . Implanted brand stent target vessel within 1 year . 5 . Left Ventricular Ejection Fraction ( LVEF ) ＜30％ 6 . Cardiogenic shock haemodynamics abnormal , need inotropic agent mechanical support . 7 . The subject allergic asprin , heparin , clopidogrel/ticlopidine , stainless steel alloy , Arsenic trioxide , sirolimus , styrenebutenestyrene polylactic acid ( PLA ) polymer contrast agent . 8 . Severe tortuous and/or heavy calcification lesion . 9 . Two proximal chronic total occlusion lesion . 10 . Bifurcation lesion double stent . 11 . The subject multi vessel lesion implant brand stent 12 . The subject investigator considers he/she unfit implant AVI stent Firebird 2 stent . 13 . The subject attend drug/device study followup period .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2013</verification_date>
</DOC>